Murrieta, CA, United States of America

Mark Andrew Ritchart

This inventor holds 68 USPTO granted patents and 8 published patent applications, plus 8 CIPO patents and 8 EPO patents, primarily in Arteriovenous Fistula Creation (CPC class A61B). Top assignees: Avenu Medical, Inc., Ethicon Endo-Surgery, Inc., Devicor Medical Products, Inc.. Active years: 1988-2025.

USPTO Granted Patents = 68 

% Patents Active = 79.4

 

 

Average Co-Inventor Count = 3.5

ph-index = 32

Forward Citations = 10,157(Granted Patents)

Forward Citations (Not Self Cited) = 9,895(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Orange, CA (US) (1988)
  • Murietta, CA (US) (1995)
  • Murrietta, CA (US) (2013 - 2014)
  • Murrieta, CA (US) (1993 - 2024)
  • Dana Point, CA (US) (2016 - 2024)

Company Filing History:


Years Active: 1988-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Arteriovenous Fistula
Biologic Grafts
Brachytherapy
Percutaneous Access
Tissue Welding
Catheter Control
Vascular Fixation
Anastomosis Techniques
Automated Biopsy
Soft Tissue Collection
Multi-Component Anchor
Tissue Marking
68 patents (USPTO):Explore Patents

Title: Innovative Contributions of Mark Andrew Ritchart in Medical Technology

Introduction: Mark Andrew Ritchart, a prolific inventor based in Murrieta, CA, has made significant strides in the field of medical technology. With an impressive portfolio of 66 patents, his work primarily focuses on improving vascular access procedures, demonstrating his commitment to advancing healthcare through innovation.

Latest Patents: Among his most recent patents are groundbreaking technologies such as "Systems and methods for catheter feedback and control for AV fistula creation." This invention streamlines catheter operation by monitoring a gap feedback signal that indicates the distance between tissue contact surfaces. The user interface enables the graphical depiction of these surfaces while providing gap distance warnings when the distance falls outside a target range. Another notable patent is the "Intravascular arterial to venous anastomosis and tissue welding catheter." This method involves creating an arteriovenous (AV) fistula by inserting a guidewire into the second vessel, clamping tissue, and applying energy to create and weld an aperture between vessels, thereby facilitating improved medical outcomes.

Career Highlights: Mark's career includes formidable experiences with notable companies such as Avenu Medical, Inc. and Ethicon Endo-Surgery, Inc. His contributions in these organizations have helped pioneer advancements in catheter technology and vascular health management.

Collaborations: Throughout his career, Mark has collaborated with esteemed colleagues such as Fred H. Burbank and Seth Arnold Foerster. These partnerships have played a crucial role in shaping his innovative designs and applications in the realm of medical devices.

Conclusion: Mark Andrew Ritchart's contributions to the field of medical technology through his 66 patents emphasize the impact of innovation on healthcare. His dedication to improving vascular procedures and enhancing patient outcomes continues to inspire future advancements within the industry. As he pushes the boundaries of medical technology, Mark remains a key figure in the ongoing evolution of healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…